Mature T-cell lymphoma favoring PTCL-NOS diagnosed from pleural effusion cytology: a rare case report

Introduction Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an uncommon and heterogeneous subtype of mature T-cell non-Hodgkin lymphoma that is diagnosed by exclusion. Its clinical presentation is often nonspecific, and primary manifestation as pleural effusion is rare, which may lead to diagnostic difficulty and delayed treatment. Accurate identification of the etiology of unexplained pleural effusion is therefore essential. This report highlights the diagnostic value of cytology and immunohistochemistry (IHC) in a rare case of mature T-cell lymphoma presenting predominantly with pleural effusion, with findings favoring PTCL-NOS. A 79-year-old Chinese woman presented with dyspnea and left pleural effusion. Initial clinical and radiologic investigations suggested pneumonia with associated inflammatory pulmonary changes, moderate pleural effusion, and mild mediastinal lymphadenopathy, with a maximum lymph node diameter of 12 mm. Despite anti-infective treatment, the pleural effusion persisted. Cytologic examination of pleural fluid was performed to evaluate the underlying cause of the effusion. Atypical cells were identified and were initially considered suggestive of epithelial origin. To further characterize these cells, IHC analysis was carried out, including CD3, CD4, CD45, and other T-lymphocyte markers, together with B-cell and epithelial markers. The Ki-67 proliferation index and Epstein-Barr virus-encoded RNA (EBER) in situ hybridization were also assessed. The tumor cells were positive for CD3, CD4, and CD45, while negative for B-cell, epithelial, and other T-lymphocyte markers, supporting a diagnosis of mature T-cell lymphoma, favoring PTCL-NOS. Definitive subclassification was limited by the absence of tissue biopsy, flow cytometry, and molecular clonality testing. This case demonstrates that a mature T-cell lymphoma with features favoring PTCL-NOS may present primarily as pleural effusion and mimic more common infectious or epithelial malignant conditions, creating a significant diagnostic challenge. The findings emphasize the importance of comprehensive cytologic and IHC evaluation of pleural fluid in patients with persistent unexplained effusions. In particular, the inclusion of CD45 was critical in distinguishing non-Hodgkin lymphoma from carcinoma and other causes of pleural effusion. The case is notable for the rarity of T-cell lymphoma with pleural effusion as the main presenting feature and supports previous observations that lymphoma should be considered in the differential diagnosis of atypical pleural cytology. Cytology and IHC can confirm hematolymphoid lineage and narrow the differential diagnosis, but definitive subclassification of a suspected PTCL-NOS requires tissue biopsy, flow cytometry, and molecular clonality testing. Nevertheless, systematic IHC workup of pleural fluid remains a critical first step toward accurate diagnosis and timely management in such rare presentations.

Authors

Publication Details

Journal
Biomedicine Hub
Published
2026-11-19
DOI
https://doi.org/10.1159/bmh/aboag013
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mature T-cell lymphoma favoring PTCL-NOS diagnosed from pleural effusion cytology: a rare case report

Zhongjiao Chen, Long Wang, Lina Wang, Jie Jian
Biomedicine Hub
Lymphoma Diagnosis and Treatment
article

Mature T-cell lymphoma favoring PTCL-NOS diagnosed from pleural effusion cytology: a rare case report

Zhongjiao Chen, Long Wang, Lina Wang, Jie Jian
article en

Abstract

Introduction Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an uncommon and heterogeneous subtype of mature T-cell non-Hodgkin lymphoma that is diagnosed by exclusion. Its clinical presentation is often nonspecific, and primary manifestation as pleural effusion is rare, which may lead to diagnostic difficulty and delayed treatment. Accurate identification of the etiology of unexplained pleural effusion is therefore essential. This report highlights the diagnostic value of cytology and immunohistochemistry (IHC) in a rare case of mature T-cell lymphoma presenting predominantly with pleural effusion, with findings favoring PTCL-NOS. A 79-year-old Chinese woman presented with dyspnea and left pleural effusion. Initial clinical and radiologic investigations suggested pneumonia with associated inflammatory pulmonary changes, moderate pleural effusion, and mild mediastinal lymphadenopathy, with a maximum lymph node diameter of 12 mm. Despite anti-infective treatment, the pleural effusion persisted. Cytologic examination of pleural fluid was performed to evaluate the underlying cause of the effusion. Atypical cells were identified and were initially considered suggestive of epithelial origin. To further characterize these cells, IHC analysis was carried out, including CD3, CD4, CD45, and other T-lymphocyte markers, together with B-cell and epithelial markers. The Ki-67 proliferation index and Epstein-Barr virus-encoded RNA (EBER) in situ hybridization were also assessed. The tumor cells were positive for CD3, CD4, and CD45, while negative for B-cell, epithelial, and other T-lymphocyte markers, supporting a diagnosis of mature T-cell lymphoma, favoring PTCL-NOS. Definitive subclassification was limited by the absence of tissue biopsy, flow cytometry, and molecular clonality testing. This case demonstrates that a mature T-cell lymphoma with features favoring PTCL-NOS may present primarily as pleural effusion and mimic more common infectious or epithelial malignant conditions, creating a significant diagnostic challenge. The findings emphasize the importance of comprehensive cytologic and IHC evaluation of pleural fluid in patients with persistent unexplained effusions. In particular, the inclusion of CD45 was critical in distinguishing non-Hodgkin lymphoma from carcinoma and other causes of pleural effusion. The case is notable for the rarity of T-cell lymphoma with pleural effusion as the main presenting feature and supports previous observations that lymphoma should be considered in the differential diagnosis of atypical pleural cytology. Cytology and IHC can confirm hematolymphoid lineage and narrow the differential diagnosis, but definitive subclassification of a suspected PTCL-NOS requires tissue biopsy, flow cytometry, and molecular clonality testing. Nevertheless, systematic IHC workup of pleural fluid remains a critical first step toward accurate diagnosis and timely management in such rare presentations.

Biomedicine Hub
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon